TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15128636

Group type: EXPERIMENTAL
Intervention: Sevoflurane 1 to 3% with 60% nitrous oxide in oxygen
Number of subjects: 103

Group type: COMPARATOR
Intervention: Propofol 4 to 10 mg x kg(‐1) x hr(‐1) with 60% nitrous oxide in oxygen
Number of subjects: 103
Study: 11260586

Group type: EXPERIMENTAL
Intervention: Hydrotherapy (37 degrees C water for 1 hr during early labor)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (nonbathers)
Number of subjects: 18
Study: 9561872

Group type: EXPERIMENTAL
Intervention: Polyurethane condom
Number of subjects: 360

Group type: COMPARATOR
Intervention: Latex condom
Number of subjects: 360
Study: 7872995

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol sulfate (Asmasal) at 0.1 mg/kg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol sulfate (Asmasal) at 0.2 mg/kg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol sulfate (Asmasal) at 0.3 mg/kg
Number of subjects: 11
Study: 3243221

Group type: EXPERIMENTAL
Intervention: Classroom curriculum
Number of subjects: 1839

Group type: EXPERIMENTAL
Intervention: Home-based curriculum
Number of subjects: 1839

Group type: EXPERIMENTAL
Intervention: Combination of classroom and home-based curriculum
Number of subjects: 1839

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1839
Study: 29192349

Group type: EXPERIMENTAL
Intervention: Placement of an antibiotic oral pack on the hard palate for 5 days postoperatively (Group A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No oral pack placed (Group B)
Number of subjects: 200
Study: 27404011

Group type: EXPERIMENTAL
Intervention: Make-The-Cut-Plus (MTC+) intervention
Number of subjects: 1226

Group type: COMPARATOR
Intervention: Control group (received MTC+ at the end of the period)
Number of subjects: 1226
Study: 24000883

Group type: EXPERIMENTAL
Intervention: Interprofessional education (IPE) debate in ethics and professionalism
Number of subjects: 0
Study: 22452894

Group type: EXPERIMENTAL
Intervention: Hormone therapy plus celecoxib (arm D)
Number of subjects: 2043

Group type: COMPARATOR
Intervention: Hormone therapy alone (control arm A)
Number of subjects: 2043
Study: 20736674

Group type: EXPERIMENTAL
Intervention: Simulation training in ultrasound-guided central venous catheter insertion (CVC)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Traditional bedside apprenticeship model
Number of subjects: 185
Study: 17609682

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nelfinavir
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Efavirenz and Nelfinavir
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dose adjustment
Number of subjects: 50
Study: 15806597

Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure and ritual prevention (EX/RP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of EX/RP and CMI (EX/RP+CMI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EX/RP (with or without CMI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CMI alone
Number of subjects: 0
Study: 12226610

Group type: EXPERIMENTAL
Intervention: new brackets
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted/sealant
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted/silane
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted/HF
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted/HF/sealant
Number of subjects: 120
Study: 10217646

Group type: EXPERIMENTAL
Intervention: Preconditioning (PC) during PTCA
Number of subjects: 150

Group type: COMPARATOR
Intervention: Unrestricted approach to balloon angioplasty (UC)
Number of subjects: 150
Study: 7879933

Group type: EXPERIMENTAL
Intervention: Atracurium (0.5 mg.kg-1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.1 mg.kg-1)
Number of subjects: 16
Study: 2196355

Group type: EXPERIMENTAL
Intervention: Dexamethasone, 2 mg/kg/day by intravenous injection during the first 7 days of life (group A1)
Number of subjects: 466

Group type: COMPARATOR
Intervention: 10% dextrose solution placebo (group A2)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Prenatal betamethasone (group B)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Dexamethasone (group A1)
Number of subjects: 466
Study: 7005306

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 30659815

Group type: EXPERIMENTAL
Intervention: Short-term ontopsychological psychotherapy plus routine medical therapy
Number of subjects: 94

Group type: COMPARATOR
Intervention: Routine medical therapy only
Number of subjects: 94
Study: 25985845

Group type: EXPERIMENTAL
Intervention: LMA‐P Group
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: ETT Group
Number of subjects: 58

Group type: COMPARATOR
Intervention: DLT Group
Number of subjects: 58
Study: 23389795

Group type: EXPERIMENTAL
Intervention: Training on anatomic dry models
Number of subjects: 14

Group type: COMPARATOR
Intervention: Training only on cadaveric specimens
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dry-model training
Number of subjects: 14
Study: 20147571

Group type: EXPERIMENTAL
Intervention: MRK-409 at a dose of 2 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: MRK-409 at a dose of 1 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rodent models of anxiety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rodent models
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19672771

Group type: EXPERIMENTAL
Intervention: CDA 0.14 mg/kg/day for 5 days (Arm A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: CDA 0.14 mg/kg/day once weekly for 5 weeks (Arm B)
Number of subjects: 100
Study: 17099023

Group type: EXPERIMENTAL
Intervention: Dosimeter method
Number of subjects: 25

Group type: COMPARATOR
Intervention: Tidal-breathing method
Number of subjects: 25
Study: 15100717

Group type: EXPERIMENTAL
Intervention: 3.5 g/day fish oil (1.5 g/day n-3 fatty acids)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 11167438

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg at induction and ondansetron 0.13 mg with each 1-mg bolus dose of morphine
Number of subjects: 142

Group type: COMPARATOR
Intervention: Droperidol 0.5 mg at induction and droperidol 0.05 mg per 1-mg bolus dose of morphine
Number of subjects: 142
Study: 9924238

Group type: EXPERIMENTAL
Intervention: itraconazole 200 mg orally, once daily for 4 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 7508827

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium chloride (0.3 mEq/kg bolus over 10 minutes followed by 0.08 mEq/kg per hour for 24 hours)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium chloride
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (5% dextrose in water)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2906956

Group type: EXPERIMENTAL
Intervention: labetalol (1 mg/kg i.v. 15 min)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: nifedipine (20 mg sublingually)
Number of subjects: 32
Study: 29318916

Group type: EXPERIMENTAL
Intervention: Wearable activity tracker (Misfit Flash) provided to students in the intervention group
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (no wearable activity tracker)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Intervention group (wearable activity tracker)
Number of subjects: 187
Study: 27438294

Group type: EXPERIMENTAL
Intervention: Philani Intervention Program (PIP) with home visits by Community Health Workers (CHW)
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Philani Intervention Program (PIP)
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 1238
Study: 24726210

Group type: EXPERIMENTAL
Intervention: losartan 150 mg/d
Number of subjects: 3846

Group type: COMPARATOR
Intervention: losartan 50 mg/d
Number of subjects: 3846
Study: 23275363

Group type: EXPERIMENTAL
Intervention: Exenatide once weekly (EQW) 2 mg
Number of subjects: 216

Group type: COMPARATOR
Intervention: Insulin detemir (once or twice daily, titrated)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Exenatide once weekly (EQW)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Insulin detemir
Number of subjects: 216
Study: 21988800

Group type: EXPERIMENTAL
Intervention: Collaborative care (a low intensity psychological intervention in addition to usual general practitioner care)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Usual general practitioner care alone
Number of subjects: 540
Study: 18422677

Group type: EXPERIMENTAL
Intervention: Children with intractable epilepsy (IE)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Children with intractable epilepsy (IE) and cerebral palsy (CP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy children
Number of subjects: 25
Study: 16931258

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.4% for 3 days
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.4% for 1 day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.4% for 1 hour
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 12743562

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with a standardized latex extract
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10974044

Group type: EXPERIMENTAL
Intervention: DHA supplementation (200 mg of DHA/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 10
Study: 8733069

Group type: EXPERIMENTAL
Intervention: Carvedilol 50 mg bid
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg bid
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Intravenous carvedilol followed by oral carvedilol 50 mg bid for 8 weeks
Number of subjects: 29
Study: 1303781

Group type: EXPERIMENTAL
Intervention: Immunologically active peat preparation (PTT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3510946

Group type: EXPERIMENTAL
Intervention: cis-dichlorodiammine platinum (II) (cis-DPP) with radiation
Number of subjects: 45

Group type: COMPARATOR
Intervention: radiation
Number of subjects: 45
Study: 28941040

Group type: EXPERIMENTAL
Intervention: TPB messages
Number of subjects: 2951

Group type: COMPARATOR
Intervention: Self-affirmation and implementation intentions
Number of subjects: 2951
Study: 26946967

Group type: EXPERIMENTAL
Intervention: Probiotic S. boulardii (50 mg/kg twice daily)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (no probiotic)
Number of subjects: 125
Study: 23596009

Group type: EXPERIMENTAL
Intervention: Dietary intervention to reduce the n-6/n-3 fatty acid ratio from 15th week of gestation until 4 months postpartum
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Cord leptin
Number of subjects: 208
Study: 22631051

Group type: EXPERIMENTAL
Intervention: Intermittent bolus application of propofol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Continuous infusion of propofol
Number of subjects: 100
Study: 20456855

Group type: EXPERIMENTAL
Intervention: Antenatal care visits provided by a community midwife at a local clinic, 10 visits
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antenatal care visits provided by a community midwife at a local clinic
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antenatal care visits provided by midwives with enhanced service provision
Number of subjects: 100
Study: 19024097

Group type: EXPERIMENTAL
Intervention: Firebird sirolimus eluting stent (SES)
Number of subjects: 509
Study: 19822590

Group type: EXPERIMENTAL
Intervention: Guided imagery treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard medical care only
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Guided imagery treatment after standard medical care
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Guided imagery treatment effects maintained for 6 months
Number of subjects: 34
Study: 15190043

Group type: EXPERIMENTAL
Intervention: High-flavonoid dark chocolate (213 mg procyanidins, 46 mg epicatechin)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-flavonoid dark chocolate (46 g, 1.6 oz)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High-flavonoid dark chocolate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-flavonoid dark chocolate
Number of subjects: 21
Study: 11735841

Group type: EXPERIMENTAL
Intervention: Usual care plus a 15-session group cognitive therapy prevention program
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 94
Study: 9470494

Group type: EXPERIMENTAL
Intervention: DCPD dentifrices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DCPD/fluoride dentifrice
Number of subjects: 0
Study: 8192116

Group type: EXPERIMENTAL
Intervention: Two doses of ondansetron (0.15 mg/kg) with dexamethasone (20 mg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Three doses of ondansetron (0.15 mg/kg) with dexamethasone (20 mg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Combination of ondansetron and dexamethasone
Number of subjects: 44
Study: 2854886

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide and ACTH
Number of subjects: 16

Group type: COMPARATOR
Intervention: ACTH alone
Number of subjects: 16
Study: 31983034

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive (COC) users
Number of subjects: 62

Group type: COMPARATOR
Intervention: Non-COC users
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Very low dose COCs (20 mcg EE)
Number of subjects: 62
Study: 31310442

Group type: EXPERIMENTAL
Intervention: Cytokine-based prediction models using IL-6, IL-27, and CRP
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 344
Study: 27926561

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate ointment (twice daily for 8 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Percutaneous posterior tibial nerve stimulation (30-minute session 2 days per week for 8 weeks)
Number of subjects: 80
Study: 26321186

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 23525894

Group type: EXPERIMENTAL
Intervention: MK-7 (180 μg MK-7/day)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 21477878

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 0
Study: 19682342

Group type: EXPERIMENTAL
Intervention: IV ferric carboxymaltose (≤1000 mg over 15 min, repeated weekly)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Ferrous sulfate (325 mg orally thrice daily for 6 weeks)
Number of subjects: 477
Study: 16769917

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Single-chamber ICD
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Dual-chamber ICD
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Life-prolonging therapy from the ICD
Number of subjects: 1218
Study: 15128007

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy following surgery
Number of subjects: 925

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 925
Study: 11795434

Group type: EXPERIMENTAL
Intervention: Finasteride (5-alpha-reductase inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selenium and Vitamin E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation and diet modification
Number of subjects: 0
Study: 9397979

Group type: EXPERIMENTAL
Intervention: Lactulose (45 mL/d) for 8 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Nontreated (control group)
Number of subjects: 75
Study: 7535496

Group type: EXPERIMENTAL
Intervention: Infusion therapy
Number of subjects: 0
Study: 3653083

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 30905182

Group type: EXPERIMENTAL
Intervention: Cognitive correction training (40 sessions, 30 minutes each, 5 sessions per week)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 29774412

Group type: EXPERIMENTAL
Intervention: Hybrid constructs (sublaminar bands on concave side and pedicle screw)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Pedicle screws only
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Hybrid constructs (sublaminar bands)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37
Study: 27058907

Group type: EXPERIMENTAL
Intervention: Medication Therapy Management review and CVD risk assessment and education
Number of subjects: 723

Group type: COMPARATOR
Intervention: Usual care (usual pharmacist care with no specific intervention)
Number of subjects: 723
Study: 25504176

Group type: EXPERIMENTAL
Intervention: Dyadic music therapy intervention (10 weekly sessions)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 18
Study: 22824755

Group type: EXPERIMENTAL
Intervention: Fermented papaya preparation (FPP) 9g/day (4.5g twice a day sublingually) for 6 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fermented papaya preparation (FPP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 20846428

Group type: EXPERIMENTAL
Intervention: Weekly CCQ assessment
Number of subjects: 121
Study: 18663298

Group type: EXPERIMENTAL
Intervention: Chlorhexidine varnish
Number of subjects: 0
Study: 15956086

Group type: EXPERIMENTAL
Intervention: beta-endorphin (250 mug/h)
Number of subjects: 23

Group type: COMPARATOR
Intervention: naloxone (8 mg) preceding beta-endorphin infusion
Number of subjects: 23
Study: 12141468

Group type: COMPARATOR
Intervention: Filtered dialysate
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: All four modalities of HD (F 60, F 500S, Tricea 150G, Tricea 150Gf)
Number of subjects: 37
Study: 9564059

Group type: EXPERIMENTAL
Intervention: CO2 exposure during operative laparoscopy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (laparotomy)
Number of subjects: 28
Study: 8605417

Group type: EXPERIMENTAL
Intervention: Bony decompression
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diskectomy
Number of subjects: 6
Study: 2692962

Group type: EXPERIMENTAL
Intervention: HRP112 (depot‐medroxyprogesterone acetate, 25 mg and estradiol cypionate, 5 mg)
Number of subjects: 2320

Group type: EXPERIMENTAL
Intervention: HRP102 (norethisterone enantate, 50 mg and estradiol valerate, 5 mg)
Number of subjects: 2320
Study: 48894

Group type: EXPERIMENTAL
Intervention: Procainamide (500 mg, 4-hourly)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mexiletine (250 mg, 8-hourly)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 29148088

Group type: EXPERIMENTAL
Intervention: Intensive intervention (four weekly group sessions and two motivational follow-up calls)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Individual standardized brief counseling on healthy lifestyles
Number of subjects: 208
Study: 26828618

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 24801818

Group type: EXPERIMENTAL
Intervention: Comprehensive services of a Certified Child Life Specialist (CCLS)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Standard of care (no child life services)
Number of subjects: 137
Study: 22856637

Group type: EXPERIMENTAL
Intervention: 0.5 mg/day of jet‐nebulized budesonide inhalation suspension (BIS)
Number of subjects: 53

Group type: COMPARATOR
Intervention: 40-60 mg/day of cromolyn sodium inhalation suspension (CIS)
Number of subjects: 53
Study: 20070953

Group type: EXPERIMENTAL
Intervention: Internet-based self-help writing intervention
Number of subjects: 757

Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 757
Study: 18701019

Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control
Number of subjects: 220
Study: 15934131

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: Monthly telephone contact
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: Exercise therapy and telephone contact
Number of subjects: 759

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 759
Study: 12870698

Group type: COMPARATOR
Intervention: Type I diabetic subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Type II diabetic subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Control subjects
Number of subjects: 0
Study: 11383809

Group type: EXPERIMENTAL
Intervention: Water seal
Number of subjects: 140

Group type: COMPARATOR
Intervention: Suction
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Water seal (after randomization ended)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Water seal (with leaks 4/7 or greater)
Number of subjects: 140
Study: 9183510

Group type: EXPERIMENTAL
Intervention: Group-based relapse prevention (G-RP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Individually based relapse prevention (I-RP)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Relapse prevention treatment (both formats)
Number of subjects: 32
Study: 1586782

Group type: EXPERIMENTAL
Intervention: Diet A (fat reduced diet rich in soluble dietary fibre, antioxidant vitamins, and minerals, advised to eat more fruit, vegetables, nuts, and grain products)
Number of subjects: 505

Group type: COMPARATOR
Intervention: Diet B (fat reduced diet)
Number of subjects: 505
Study: 3886398

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31350924

Group type: EXPERIMENTAL
Intervention: mCAF + ADMG
Number of subjects: 22

Group type: COMPARATOR
Intervention: CAF + ADMG
Number of subjects: 22